Julie Krop - Net Worth and Insider Trading
Julie Krop Net Worth
The estimated net worth of Julie Krop is at least $1 Million dollars as of 2024-05-12. Julie Krop is the Chief Medical Officer of AMAG Pharmaceuticals Inc and owns about 81,399 shares of AMAG Pharmaceuticals Inc (AMAG) stock worth over $1 Million. Details can be seen in Julie Krop's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Julie Krop has not made any transactions after 2019-05-28 and currently still holds the listed stock(s).
Transaction Summary of Julie Krop
Julie Krop Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Julie Krop owns 2 companies in total, including AMAG Pharmaceuticals Inc (AMAG) , and Aquestive Therapeutics Inc (AQST) .
Click here to see the complete history of Julie Krop’s form 4 insider trades.
Insider Ownership Summary of Julie Krop
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AMAG | AMAG Pharmaceuticals Inc | 2020-03-02 | Chief Medical Officer |
| AQST | Aquestive Therapeutics Inc | 2021-02-10 | director |
Julie Krop Latest Holdings Summary
Julie Krop currently owns a total of 1 stock. Julie Krop owns 81,399 shares of AMAG Pharmaceuticals Inc (AMAG) as of May 28, 2019, with a value of $1 Million.
Latest Holdings of Julie Krop
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AMAG | AMAG Pharmaceuticals Inc | 2019-05-28 | 81,399 | 13.75 | 1,119,236 |
Holding Weightings of Julie Krop
Julie Krop Form 4 Trading Tracker
According to the SEC Form 4 filings, Julie Krop has made a total of 1 transactions in AMAG Pharmaceuticals Inc (AMAG) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in AMAG Pharmaceuticals Inc is the acquisition of 10,000 shares on May 28, 2019, which cost Julie Krop around $99,100.
Insider Trading History of Julie Krop
- 1
Julie Krop Trading Performance
GuruFocus tracks the stock performance after each of Julie Krop's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Julie Krop is 5.5%. GuruFocus also compares Julie Krop's trading performance to market benchmark return within the same time period. The performance of stocks bought by Julie Krop within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Julie Krop's insider trading performs compared to the benchmark.
Performance of Julie Krop
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 1.73 | | | | | |
| Relative Return to S&P 500(%) | -3.24 | | | | | |
Julie Krop Ownership Network
Julie Krop Owned Company Details
What does AMAG Pharmaceuticals Inc do?
Who are the key executives at AMAG Pharmaceuticals Inc?
Julie Krop is the Chief Medical Officer of AMAG Pharmaceuticals Inc. Other key executives at AMAG Pharmaceuticals Inc include 10 percent owner Camber Capital Management Lp , Chief Operating Officer Anthony Casciano , and Interim CFO Brian Piekos .
AMAG Pharmaceuticals Inc (AMAG) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of AMAG Pharmaceuticals Inc (AMAG) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of AMAG Pharmaceuticals Inc (AMAG) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
AMAG Pharmaceuticals Inc (AMAG)'s detailed insider trading history can be found in Insider Trading Tracker table.
AMAG Pharmaceuticals Inc Insider Transactions
Julie Krop Mailing Address
Above is the net worth, insider trading, and ownership report for Julie Krop. You might contact Julie Krop via mailing address: C/o Amag Pharmaceuticals, Inc., 1100 Winter Street, Waltham Ma 02451.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
